UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported) – December 15, 2009
________________________
WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified in its charter)
_____________________
| |
|
|
|
Pennsylvania |
1-8036 |
23-1210010 |
|
(State or other jurisdiction
of Incorporation) |
(Commission File Number) |
(IRS Employer
Identification No.) |
| |
|
|
|
101 Gordon Drive, PO Box 645, Lionville, PA |
|
19341-0645 |
|
(Address of principal executive offices) |
|
(Zip Code) |
(610) 594-2900
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or address, if changed since last report)
____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01 Regulation FD
West Pharmaceutical Services, Inc. announced today that its board of directors unanimously decided on December 15, 2009, to ask shareholders to approve a proposal to elect the entire board each year starting in 2012. A copy of the press release announcing the decision is attached to this report as Exhibit 99.1.
The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under that
Act or the Securities Act of 1933.
Item 9.01 Financial Statements and Exhibits
|
(d) |
Exhibits |
|
|
| |
|
|
|
| |
Exhibit # |
|
Description |
| |
|
|
|
| |
99.1 |
|
West Pharmaceutical Services, Inc. Press Release, dated December 21, 2009. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
WEST PHARMACEUTICAL SERVICES, INC.
/s/ John R. Gailey III
John R. Gailey III, Vice President, General
Counsel and Secretary
December 21, 2009
EXHIBIT INDEX
|
Exhibit No. |
Description |
|
99.1 |
West Pharmaceutical Services, Inc. Press Release, dated December 21, 2009. |